Ionis Pharmaceuticals
IONS
IONS
334 hedge funds and large institutions have $6.4B invested in Ionis Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 99 increasing their positions, 100 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
334
Holders Change
+20
Holders Change %
+6.37%
% of All Funds
8.77%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.18%
New
64
Increased
99
Reduced
100
Closed
39
Calls
$82.9M
Puts
$91.9M
Net Calls
-$9.09M
Net Calls Change
+$10.8M
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$78.7M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$23M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$18.6M |
| 4 |
Goldman Sachs
New York
|
+$16.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$54.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$38.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$34.5M |
| 4 |
GTP
Global Thematic Partners
New York
|
-$31.6M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
-$27M |
